SUNPHARMANSESun Pharmaceutical Industries Limited· PharmaceuticalsHighNegative
Announced Sun, 14 Jun · 11:44 IST

Intimation under Regulation 30 of SEBI (LODR) Regulations 2015

Regulatory & Legal View source PDF

SUNPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.1%1-day move
₹1807.00
prior close
₹1818.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.6-0.8-0.8-0.9-0.1+0.8+1.1+1.8+3.2+3.7+5.3+8.0
Up moveDown movePending
AI summary

Sun Pharma has informed the stock exchanges that one of its Independent Directors, Mr. Gautam Doshi, has been arrested. The company has clarified that the matter is personal and is not connected with Sun Pharma in any way. Management has stated that no impact is expected on the company's operations, financials, or board functioning. The company will monitor developments and take steps as needed.

Likely market impact

Since the company explicitly states the arrest is unrelated to Sun Pharma and no impact on the business is expected, this is likely a neutral-to-mildly-negative headline risk rather than a fundamental concern. Investors should watch for any follow-up disclosures or media developments involving the director, but near-term operational and financial impact appears limited.